Journal
CLINICAL INFECTIOUS DISEASES
Volume 57, Issue 6, Pages 849-852Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/cit376
Keywords
HSV; VZV; encephalitis; meningitis; natalizumab
Categories
Ask authors/readers for more resources
We report on 20 natalizumab-treated patients with multiple sclerosis who developed laboratory-confirmed central nervous system (CNS) herpesvirus infections. In addition to progressive multifocal leukoencephalopathy, other CNS opportunistic infections have been rarely reported during natalizumab treatment. We encourage heightened awareness due to the risk for serious outcomes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
